GlassScriptPhysician profile
Edward Zoltan
NPI 1982760302
$7,161.01
in general payments reported to CMS, 2019-2025
19 companies · $15.79 in 2025
The $15.79 reported for 2025 was less than what a typical Urology provider received nationally (typical 2025 total: $631).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2019: $460 · 2020: $537 · 2021: $1,880 · 2022: $3,736 · 2023: $229 · 2024: $303 · 2025: $15.79.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $547.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $547.33 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Acerus Pharmaceuticals Corporation | $3,707.52 | 2020-2022 | |
| Axonics, INC. | $1,486.42 | 2020-2024 | Axonics, Bulkamid |
| Astellas Pharma US INC | $476.30 | 2019-2022 | |
| Neotract INC. | $374.04 | 2020 | |
| Boston Scientific Corporation | $341.28 | 2019-2024 | Ams 800 Artificial Urinary Sphincter, Rezum Generator, Greenlight Xps |
| Teleflex LLC | $218.65 | 2021 | |
| Myriad Genetic Laboratories, INC. | $146.21 | 2021-2023 | Prolaris |
| Aytu Biopharma, INC. | $85.63 | 2019-2020 | |
| Urogen Pharma, INC. | $63.46 | 2023-2024 | Jelmyto |
| Coloplast Corp | $53.01 | 2019-2025 | |
| Smith+Nephew, INC. | $48.70 | 2019 | |
| Progenics Pharmaceuticals, INC. | $23.87 | 2024 | |
| Abbvie INC. | $22.05 | 2022 | |
| Pfizer INC. | $21.41 | 2019 | |
| Verity Pharmaceuticals INC. | $20.51 | 2023 | Trelstar |
Show all 19 companies
| Company | General payments | Years | Top products |
|---|---|---|---|
| Bayer Healthcare Pharmaceuticals INC. | $20.10 | 2019 | |
| Janssen Biotech, INC. | $19.15 | 2019 | |
| 180 Medical, INC. | $17.31 | 2019 | |
| Srs Medical Systems, INC. | $15.39 | 2023 | Urocuff |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Edward Zoltan listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.